Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
23.42 USD
-2.05%
Market Closed
Updated:
Jun 10, 2024
Arrowhead Pharmaceuticals Inc
Change in Working Capital
|
Arrowhead Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Change in Working Capital
$107.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
0%
|
CAGR 10-Years
71%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arrowhead Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
107.1m
USD
107.1m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Change in Working Capital amounts to 107.1m USD.
What is Arrowhead Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
71%
71%
The average annual Change in Working Capital growth rates for Arrowhead Pharmaceuticals Inc have been -23% over the past three years , and 71% over the past ten years .
You don't have any saved screeners yet
